An IQVIA RWE Virtual Conference
Life science innovators driving RWE impact and value
View all IQVIA events

An IQVIA Virtual Conference

Real world evidence (RWE) is creating a new world of possibilities across all therapeutic areas, helping demonstrate treatment value and commercial differentiation, spanning stakeholders throughout the life cycle.

The growing acceptance of RWE by regulators and payers means growing utility of RWE -- to enhance clinical development, to innovate reimbursement models, to help drive research forward, and to accelerate patient access to new treatments.

With technology-enabled real world data and evidence, you can efficiently demonstrate the impact RWE brings to your portfolio:

  • Gain insights that support new or improved treatment pathways
  • Discover and leverage increasingly available data sources and collection methods
  • Leverage advanced analytics to help identify undiagnosed patients and drive earlier prediction of disease progression.

Join this upcoming virtual conference to learn how you can efficiently demonstrate the impact RWE brings to your portfolio.


Speakers

Julie van Bavel
Executive Director
CORE Regional, Asia Pacific
MSD

Taara Madhavan
Regional Evidence Generation Lead
Asia Pacific Medical Affairs
Janssen

Paul Petraro, ScD., MPH
Global Head
RWE Analytics Center of Excellence, Real World Solutions
Boehringer Ingelheim

Sulabha Ramachandran
Vice President
US and Regions, Value Evidence and Outcomes
GSK

Gorana Capkun
Global Head
RWE Enablement
Novartis Oncology

Enkeleida Nikai
Head of Real World Evidence
Senior Director
Janssen Europe

Contact Us